Keywords
Small cell lung cancer, SCLC, G-CSF, HPSCs, Trilaciclib.
How to Cite
Xiong, S., & Zou, G.-M. (2025). CDK4/6 inhibition in hematologic malignancies: bone marrow protection in chemotherapy and anti-leukemic activity. American Journal of Translational Medicine, 9(3), 101–103. Retrieved from https://ajtm.journals.publicknowledgeproject.org/index.php/ajtm/article/view/3739